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Introduction
The Journal of Translational Medicine is published by Bio-
Med Central, an independent publisher committed to
ensuring peer-reviewed biomedical research is Open
Access – it is universally and freely available online to eve-
ryone, its authors retain copyright, and it is archived in at
least one internationally recognised free repository [1].
The Journal of Translational Medicine however, has taken
this further, by making all content Open Access. To fund
this, from the 1st of February, 2004 authors of articles
accepted for publication will be asked to pay an article-
processing charge (APC) of US$525.
Problems with the traditional publishing model
Traditionally, readers pay to access articles, either through
subscriptions or by paying a fee each time they download
an article. Escalating journal subscriptions have resulted
in libraries subscribing to fewer journals [2], and the range
of articles available to readers is therefore limited.
Although traditional journals publish authors' work for
free (unless there are page or colour charges), having to
pay to access articles limits how many can read, use and
cite them.
Definition of Open Access
The Journal of Translational Medicine's Open Access policy
changes the way in which articles are published. First, all
articles become freely and universally accessible online,
and so an author's work can be read by anyone at no cost.
Second, the authors hold copyright for their work and
grant anyone the right to reproduce and disseminate the
article, provided that it is correctly cited and no errors are
introduced [1]. Third, a copy of the full text of each Open
Access article is archived in an online repository separate
from the journal. The Journal of Translational Medicine's
articles are archived in PubMed Central [3], the US
National Library of Medicine's full-text repository of life
science literature; e-Depot [4], the National Library of the
Netherlands' digital archive of all electronic publications;
and Potsdam [5] and INIST [6], sites archiving the
research articles published by BioMed Central in Germany
and France, respectively.
The benefits of Open Access
Open Access has four broad benefits for science and the
general public. First, authors are assured that their work is
disseminated to the widest possible audience, given that
there are no barriers to access their work. This is accentu-
ated by the authors being free to reproduce and distribute
their work, for example by placing it on their institution's
website. It has been suggested that free online articles are
more highly cited because of their easier availability [7].
Second, the information available to researchers will not
be limited by their library's budget, and the widespread
availability of articles will enhance literature searching
and facilitate meta-analyses [8]. Third, the results of pub-
licly funded research will be accessible to all taxpayers and
not just those with access to a library with a subscription.
As such, Open Access could help to increase public inter-
est in, and support of, research. Note that this public
accessibility may become a legal requirement in the USA
if the proposed Public Access to Science Act is made law
[9]. Fourth, a country's economy will not influence its sci-
entists' ability to access articles because resource-poor
countries (and institutions) will be able to read the same
material as wealthier ones (although creating access to the
internet is another matter [10]).
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APC payment
APCs will allow continued Open Access to all of The Jour-
nal of Translational Medicine articles. Authors are asked to
pay US$525 if their article is accepted for publication.
Waiver requests will be considered on a case-by-case basis,
by the Editor-in-Chief. Authors can circumvent the charge
by getting their institution to become a 'member' of Bio-
Med Central, whereby the annual membership fee covers
the APCs for all authors at that institution for that year.
Current members include NHS England, the World
Health Organization, the US National Institutes of
Health, Harvard, Princeton and Yale universities, and all
UK universities [11]. No charge is made for articles that
are rejected after peer review. Many funding agencies have
also realized the importance of Open Access publishing
and have specified that their grants may be used directly
to pay APCs [12].
What the APC covers
The APC pays for efficient and thorough peer review, for
the article to be freely and universally accessible in various
formats online, and for the processes required for inclu-
sion in PubMed and archiving in PubMed Central, e-
Depot, Potsdam and INIST. Although some authors may
consider US$525 expensive, it must be remembered that
The Journal of Translational Medicine does not levy addi-
tional page or colour charges on top of this fee, which can
easily exceed US$525. With the article being online only,
any number of colour figures and photographs can be
included, at no extra cost.
Free versus Open Access
Although several journals now offer free access to their
articles online, this is different from Open Access (as
defined by the Bethesda Statement [13]). Journals often
delay free access for 6–12 months, and even when the full
text is available, readers are not allowed to reproduce and/
or disseminate the work because of restrictions imposed
by the copyright policy. That said, The Journal of Transla-
tional Medicine is not alone in the move to Open Access
funded by APCs. The British Medical Journal has recently
announced that it cannot continue to provide free access
to its website [14] and is considering various sources of
revenue, including APCs [15]. Also, the Public Library of
Science has set up two new Open Access journals, and
have elected to set APCs of US$1500 for each accepted
article [16]. Given that the Public Library of Science has
used television advertising to promote journals [9], the
high profile of these journals will raise awareness of Open
Access and encourage researchers in all disciplines to
understand and accept Open Access, with APCs as an
acceptable method to fund it.
Conclusion
By providing a forum for Open Access, APCs will enable
The Journal of Translational Medicine to serve the clinical
and scientific community. We believe this change will
benefit and aid scientific research, and we hope you will
support this progress by submitting your next article to an
Open Access journal.
Abbreviations
APC = article-processing charge.
References
1. BioMed Central Open Access Charter  [http://www.biomedcen
tral.com/info/about/charter]
2. Tamber PS: Is scholarly publishing becoming a monopoly? BMC
News and Views 2000, 1:1.
3. PubMed Central  [http://www.pubmedcentral.org]
4. e-Depot  [http://www.kb.nl/]
5. Potsdam  [http://www.uni-potsdam.de/over/homegd.htm]
6. INIST  [http://www.inist.fr/index_en.php]
7. Lawrence S: Free online availability substantially increases a
paper's impact. Nature 2001, 411:521.
8. Velterop J: Should scholarly societies embrace Open Access
(or is it the kiss of death)? Learned Publishing 2003, 16:167-169.
9. Open Access law introduced  [http://www.biomedcentral.com/
news/20030627/04]
10. Tan-Torres Edejer T: Disseminating health information in
developing countries: the role of the internet.  BMJ 2000,
321:797-800.
11. BioMed Central Institutional Members  [http://www.biomed
central.com/inst/]
12. Which funding agencies explicitly allow direct use of their
grants to cover article processing charges?  [http:www.human-
resources-health.com/info/faq/apc faq.asp?txt_faq_no=8]
13. Bethesda Statement on Open Access Publishing  [http://
www.earlham.edu/~peters/fos/bethesda.htm]
14. Delamothe T, Smith R: Paying for bmj.com.  BMJ 2003,
327:241-242.
15. Smith R: The BMJ will experiment with the 'author pays'
model (Rapid response to BMJ 2003;327:241–2).  [http://
bmj.com/cgi/eletters/327/7409/241#35308].
16. Public Library of Science to launch new free-access biomed-
ical journals with $9 million grant from the Gordon and
Betty Moore Foundation  [http://www.plos.org/news/
announce_moore.html]